Shibagaki Yuki, Suzuki Shigeru, Furuya Akiko, Kokumai Takahide, Takahashi Satoru
Pediatrics, Asahikawa Medical University, Asahikawa, JPN.
Cureus. 2025 Feb 3;17(2):e78457. doi: 10.7759/cureus.78457. eCollection 2025 Feb.
Thyroid function in autoimmune thyroid disease (AITD) among patients with Down syndrome (DS) sometimes exhibits fluctuations over time, but the underlying cause of this variability remains unknown. Thyrotoxicosis is often associated with Graves disease (GD) and Hashitoxicosis. Thyroid-stimulating hormone (TSH) receptor antibody (TRAb) includes thyroid-stimulating antibody (TSAb) and TSH-stimulation blocking antibody (TSBAb), causing GD or hypothyroidism, respectively. We report two patients of DS showing discordance between thyroid function and TRAbs. Case 1: A 16-year-old boy with DS was diagnosed with Hashimoto thyroiditis at age 6, with positive TSAb and TSBAb. At age 7, GD was diagnosed based on thyrotoxicosis and elevated I uptake. His TRAb became negative after 18 months of methimazole treatment. During follow-up, recurrent thyrotoxicosis with positive TRAb/TSAb improved transiently without intensified treatment. Methimazole was discontinued at age 14, but hypothyroidism with positive TSAb and negative TSBAb became evident. Case 2: An 18-year-old woman with DS was diagnosed with Hashimoto thyroiditis at age 13. She experienced recurrent transient thyroiditis with positive TRAb/TSAb. Although TSAb remained positive and TSBAb negative, hypothyroidism continued without GD. In conclusion, our findings indicate that awareness of the potential discordance between TSAb/TSBAb status and thyroid function is important for deciding appropriate treatment in DS patients with unstable thyroid function and AITD.
唐氏综合征(DS)患者自身免疫性甲状腺疾病(AITD)中的甲状腺功能有时会随时间波动,但其变异性的根本原因尚不清楚。甲状腺毒症常与格雷夫斯病(GD)和桥本甲状腺毒症相关。促甲状腺激素(TSH)受体抗体(TRAb)包括促甲状腺激素抗体(TSAb)和TSH刺激阻断抗体(TSBAb),分别导致GD或甲状腺功能减退。我们报告了两名DS患者,其甲状腺功能与TRAbs不一致。病例1:一名16岁患有DS的男孩在6岁时被诊断为桥本甲状腺炎,TSAb和TSBAb均为阳性。7岁时,根据甲状腺毒症和碘摄取升高诊断为GD。他在接受甲巯咪唑治疗18个月后TRAb转阴。在随访期间,TRAb/TSAb阳性的复发性甲状腺毒症在未强化治疗的情况下短暂改善。14岁时停用甲巯咪唑,但TSAb阳性和TSBAb阴性的甲状腺功能减退变得明显。病例2:一名18岁患有DS的女性在13岁时被诊断为桥本甲状腺炎。她经历了TRAb/TSAb阳性的复发性短暂性甲状腺炎。尽管TSAb仍为阳性且TSBAb为阴性,但甲状腺功能减退持续存在,未出现GD。总之,我们的研究结果表明,对于甲状腺功能不稳定且患有AITD的DS患者,认识到TSAb/TSBAb状态与甲状腺功能之间潜在的不一致对于决定适当的治疗很重要。